肝硬変におけるハイパーダイナミック循環:酸化窒素の役割
1Wellcome Research Laboratories, Langley Court, Beckenham, Kent, UK.
Lancet (London, England)
|March 30, 1991
まとめ
肝硬変は,酸化窒素 (NO) の生成が増加したため,低血圧を引き起こす. この強力な血管拡張剤である酸化窒素は,肝臓疾患の患者の血管抵抗性が低く,血管縮剤に対する感受性が低下する.
科学分野:
- 心血管生理学 心血管の生理学
- 肝臓病理学 肝臓病理学
- 血管生物学 血管生物学
背景:
- 肝硬変の特徴は,低血圧,低全身血管抵抗,および血管縮器の感度低下である.
- これらの血液動力学的変化は,血管拡張剤の過剰生産に起因する可能性があります.
- 酸化窒素 (NO) は,外周血管によって合成され,放出される重要な血管拡張剤です.
研究 の 目的:
- 肝硬変に関連した心血管の変化における酸化窒素 (NO) の役割を調査する.
- 肝硬変におけるエンドトキセミアと持続的なNO合成酵素誘導の間の潜在的な関連性を調査する.
主な方法:
- エンドトキシンとサイトカイン誘発 NO 合成酵素の発現に関する既存の動物実験のレビュー.
- 持続的なNO放出による血管トーンに対する生理学的効果の分析.
- 肝硬変におけるエンドトキシミアの罹患率と観察された血液動力学的変化の相関.
主要な成果:
- 動物の研究は,細菌のエンドトキシンとサイトカインがNO合成酵素を誘導し,持続的なNO放出と低血圧を引き起こすことを示しています.
- エンドトキセミアは,肝硬変の患者に頻繁に見られる合併症です.
- NO合成酵素の持続的誘導は,肝硬変の特徴的な血液動力学的プロフィールの基礎であると仮定されています.
結論:
- 酸化窒素 (NO) の合成と放出の増加は,肝硬変で観察される低血圧と低全身血管抵抗に大きく寄与する可能性があります.
- 肝硬変に共通するエンドトキセミアによって引き起こされる可能性のあるNO合成酵素の持続的誘導は,これらの持続的な血液動力学的変化を説明する可能性があります.
- NOの生成経路をターゲットにすることで,肝疾患における心血管機能不全の管理のための治療戦略を提供することができる.
関連する概念動画
Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


